Why Monolithic Power Systems Stock Rose Nearly 15% in May
The power-management chip company kicked off the month with solid earnings.
Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability
A compound called ERX-41 targets a previously unrecognized vulnerability in difficult-to-treat types of cancer including triple-negative breast cancer. The compound will be studied as a drug for clinical translation.
The Toro Company (TTC) Q2 2022 Earnings Call Transcript
TTC earnings call for the period ending March 31, 2022.
Why Regeneron Wasn’t a Healthy Stock Today
The company is forking over $900 million in an upfront payment to fully own a cancer drug.